|Articles|June 15, 2019
- BioPharm International-06-15-2019
- Volume 2019 eBook
- Issue 2
Single-Use Bioreactors Unwrap Commercial Manufacturing Options
Author(s)Amber Lowry
This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.
Advertisement
Several companies have invested in 2000-L single-use bioreactors to expand production capabilities, including Thermo Fisher Scientific, GE Healthcare, Pall Biotech, and Sartorius Stedim Biotech. This article highlights the features, functions, and capacities of several large-volume bioreactors by these companies that are used in the market today.
Read
Article Details
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 24–27
Citation
When referring to this article, please cite it as A. Lowry, "Single-Use Bioreactors Unwrap Commercial Manufacturing Options," BioPharm International Single-Use Systems eBook (June 2019).
Articles in this issue
over 6 years ago
New Strategies for Managing Single-Use Componentsover 6 years ago
The Importance of Single-Use Components for Bioprocessingover 6 years ago
Buffers Benefit from Single-Use Systemsover 6 years ago
Thinking Flexibly in BiomanufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
